ZA814394B - Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition - Google Patents

Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition

Info

Publication number
ZA814394B
ZA814394B ZA814394A ZA814394A ZA814394B ZA 814394 B ZA814394 B ZA 814394B ZA 814394 A ZA814394 A ZA 814394A ZA 814394 A ZA814394 A ZA 814394A ZA 814394 B ZA814394 B ZA 814394B
Authority
ZA
South Africa
Prior art keywords
cephalosporine
sulphoxides
derivatives
preparation
pharmaceutical composition
Prior art date
Application number
ZA814394A
Other languages
English (en)
Inventor
Bernard Labeeuw
Ali Sahli
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA814394B publication Critical patent/ZA814394B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA814394A 1980-06-30 1981-06-29 Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition ZA814394B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8014512A FR2485540A1 (fr) 1980-06-30 1980-06-30 Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
ZA814394B true ZA814394B (en) 1982-09-29

Family

ID=9243670

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA814392A ZA814392B (en) 1980-06-30 1981-06-29 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms
ZA814394A ZA814394B (en) 1980-06-30 1981-06-29 Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA814392A ZA814392B (en) 1980-06-30 1981-06-29 1,2,4-triazinylthiomethyl-3-cepheme sulfoxide procedure for preparation and deledic forms

Country Status (4)

Country Link
JP (2) JPS5738785A (xx)
AU (1) AU7241081A (xx)
FR (1) FR2485540A1 (xx)
ZA (2) ZA814392B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367228A (en) * 1980-10-29 1983-01-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compound and composition
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
BRPI0413908A (pt) * 2003-08-25 2006-10-24 Revaax Pharmaceuticals Llc formulação farmacêutica neuroterapêutica em forma de dosagem oral, composto, e, método de tratamento de um distúrbio comportamental ou um distúrbio cognitivo

Also Published As

Publication number Publication date
FR2485540B1 (xx) 1984-02-24
JPS5738786A (en) 1982-03-03
FR2485540A1 (fr) 1981-12-31
AU7241081A (en) 1982-01-07
ZA814392B (en) 1982-07-28
JPS5738785A (en) 1982-03-03

Similar Documents

Publication Publication Date Title
GB2016499B (en) Inclusion complexes of indomethacin their preparation and pharmaceutical compositions containing them
IL61936A (en) Derivatives of cba2 and pharmaceutical compositions containing them
IL56411A (en) Derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides,their preparation and pharmaceutical compositions containing them
IL58079A0 (en) Fabrinolytic enzyme derivatives their preparation and pharmaceutical compositions containing them
GB2091262B (en) 3-aminoprpoxyaryl derivatives their preparation and pharmaceutical compositions containing them
PT75827B (en) Process for the preparation of heterocyclic derivatives of phenlthiadiazinone oxadiazinone and triadiazinone and pharmaceutical compositions therewith
MY8700186A (en) 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
PH15937A (en) Thiazolidine derivatives and their pharmaceutical compositions
IL56821A0 (en) Heterocycylcarbonyl derivatives of ure and pharmaceutical composition containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL63965A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
IL58681A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
NZ192142A (en) Cephalosporin derivatives and pharmaceutical compositions
GB2118551B (en) Furan derivatives and pharmaceutical compositions containing them
ZA814394B (en) Derivatives of cephalosporine sulphoxides:preparation and pharmaceutical composition
GB2082583B (en) Derivatives of vincaleukoblastine their preparation and pharmaceutical formulations containing them
GB2067560B (en) 1-phenyl-4-morpholino-1-buten-3-ol derivatives their preparation and compositions containing them
ZA817568B (en) Derivatives of piperazine:procedure for their preparation and related pharmaceutical compositions
IL58438A0 (en) Isoquinoline derivatives their preparation and pharmaceutical compositions containing them
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
IL61038A0 (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them